Article Details
Retrieved on: 2023-12-19 21:20:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trial is testing the hypothesis that low doses of THIO administered prior to cemiplimab (Libtayo®) will enhance and prolong immune response in ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here